Stay updated on Clinical Trial: AZD6094 + Docetaxel in MET+ Gastric Cancer
Sign up to get notified when there's something new on the Clinical Trial: AZD6094 + Docetaxel in MET+ Gastric Cancer page.

Latest updates to the Clinical Trial: AZD6094 + Docetaxel in MET+ Gastric Cancer page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedRecruitment status on the study page was updated to indicate no further participant enrollment. New sections for How to Read a Study Record, Common Questions, How to Join a Study, and a UI revision note (Revision: v3.6.0) were added.SummaryDifference0.5%

- Check14 days agoChange DetectedThe page’s revision label was updated to v3.5.5, indicating a small update to the page’s versioning and metadata. It does not alter the study data or reported details.SummaryDifference0.1%

- Check36 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing the previous v3.5.3, indicating a new revision of the page content.SummaryDifference0.1%

- Check58 days agoChange DetectedThis updates the displayed software/page release revision from **v3.5.2** to **v3.5.3** without changing any of the clinical trial study content.SummaryDifference0.1%

- Check65 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.1%

- Check79 days agoChange DetectedNo substantive changes are visible; the study details and eligibility criteria appear unchanged. Actionable items and sections remain the same across screenshots.SummaryDifference0.1%

Stay in the know with updates to Clinical Trial: AZD6094 + Docetaxel in MET+ Gastric Cancer
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: AZD6094 + Docetaxel in MET+ Gastric Cancer page.